The pharmacology and use of H1-receptor-antagonist drugs
- PMID: 7909915
- DOI: 10.1056/NEJM199406093302307
The pharmacology and use of H1-receptor-antagonist drugs
Abstract
The second-generation H1-antagonist drugs are supplanting their predecessors in the treatment of allergic rhinoconjunctivitis and chronic urticaria. Their use can be justified mainly on the basis of a more favorable risk-benefit ratio, because they are less toxic to the central nervous system. Future research into H1 antagonists should include additional dose-response studies in patients with allergic disorders, especially children and the elderly; objective studies of adverse effects; studies of topical mucosal application of H1 antagonists; and studies of H1-antagonist enantiomers and active metabolites. With the cloning of the gene encoding the H1 receptor and increased understanding of the precise structural requirements for H1-receptor activity, H1 antagonists with an even more favorable therapeutic index may be developed.
Comment in
-
Histamine H1 antagonists.N Engl J Med. 1994 Oct 13;331(15):1019; author reply 1020. doi: 10.1056/NEJM199410133311512. N Engl J Med. 1994. PMID: 7916123 No abstract available.
-
Histamine H1 antagonists.N Engl J Med. 1994 Oct 13;331(15):1019; author reply 1020. N Engl J Med. 1994. PMID: 7916124 No abstract available.
-
Histamine H1 antagonists.N Engl J Med. 1994 Oct 13;331(15):1019; author reply 1020. N Engl J Med. 1994. PMID: 7916125 No abstract available.
-
Histamine H1 antagonists.N Engl J Med. 1994 Oct 13;331(15):1020. doi: 10.1056/NEJM199410133311513. N Engl J Med. 1994. PMID: 7916126 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources